FDA NDC Directory · JSON-LD · Markdown

olanzapine

NDC 69452-561 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerBionpharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202937
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (5 mg/1)
Marketing started20260701
Package count1

External sources

Source: openFDA. Public-domain (CC0).